• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).

作者信息

Mirouze J

出版信息

Agents Actions Suppl. 1984;15:230-58.

PMID:6385649
Abstract
摘要

相似文献

1
Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).噻氯匹定用于早期糖尿病相关微血管病变二级预防：一项多中心治疗研究方案（TIMAD研究）
Agents Actions Suppl. 1984;15:230-58.
2
The influence of ticlopidine on the natural course of retinal vein occlusion.
Agents Actions Suppl. 1984;15:219-29.
3
Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group.噻氯匹定治疗可减缓非增殖性糖尿病视网膜病变的进展。TIMAD研究组。
Arch Ophthalmol. 1990 Nov;108(11):1577-83. doi: 10.1001/archopht.1990.01070130079035.
4
Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
Agents Actions Suppl. 1984;15:60-7.
5
[Evaluation of platelet aggregation in patients treated with ticlopidine].
Clin Ter. 1984 Nov 15;111(3):247-50.
6
[The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].噻氯匹定对血小板聚集的影响：13例动脉粥样硬化患者的研究
Clin Ter. 1983 Feb 15;104(3):205-9.
7
[5-year controlled therapy study on the prevention of diabetic angiopathy with the platelet-function inhibitor acetylsalicylic acid].
Z Gesamte Inn Med. 1982 Oct 1;37(19):661-5.
8
Clinical trials of an antiplatelet agent, ticlopidine, in diabetes mellitus.抗血小板药物噻氯匹定在糖尿病中的临床试验。
Curr Med Res Opin. 1983;8(7):518-23. doi: 10.1185/03007998309109791.
9
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.在患有动脉粥样硬化性腿部动脉疾病的间歇性跛行患者中使用抑制血小板功能药物的理论依据。
Agents Actions Suppl. 1984;15:173-87.
10
The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
Agents Actions Suppl. 1984;15:279-82.

引用本文的文献

1
North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.英格兰北部循证指南制定项目：初级保健中阿司匹林用于血管疾病二级预防的指南。英格兰北部阿司匹林指南制定小组。
BMJ. 1998 Apr 25;316(7140):1303-9. doi: 10.1136/bmj.316.7140.1303.
2
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
3
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.噻氯匹定。对其药效学、药代动力学特性以及在血小板相关疾病状态下的治疗效果的综述。
Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003.